Literature DB >> 3035537

Nucleoside triphosphate-dependent DNA-binding properties of mos protein.

A Seth, E Priel, G F Vande Woude.   

Abstract

We have previously shown that the mos gene product, p40mos, produced in Escherichia coli binds ATP and has ATPase activity. In the present study, we investigated the DNA-binding properties of p40mos and two mos deletion mutant proteins. Nitrocellulose blot protein-DNA binding assays showed that p40mos binds DNA in the presence of Mg2+-ATP and certain other nucleoside triphosphates. Ninety percent of the p40mos-bound DNA is dissociated if the complex is washed in the presence of 1 M NaCl or in the absence of ATP. p40mos-DNA binding is not observed in the presence of AMP or the nonhydrolyzable ATP analog adenosine 5'-[beta, gamma-methylene]-triphosphate; however, in the presence of ADP, p40mos binds DNA at 20% of the level that is observed with ATP. An N-terminal-deletion mutant protein, p19mos, has no DNA-binding activity, whereas a C-terminal-deletion mutant protein, p25mos, does. p25mos contains the ATP-binding domain, binds DNA in the presence of either ADP or ATP, and shows 5% and 45% binding (relative to that in the presence of ATP) in the presence of AMP and adenosine 5'-[beta, gamma-methylene]triphosphate, respectively. These results suggest that the N-terminal domain of p40mos is responsible for nucleoside triphosphate-mediated DNA binding. We also observed differential histone-DNA binding in the presence and absence of ATP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035537      PMCID: PMC304914          DOI: 10.1073/pnas.84.11.3560

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  ATP-dependent specific binding of Tn3 transposase to Tn3 inverted repeats.

Authors:  W L Wishart; J R Broach; E Ohtsubo
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

2.  Sequence requirements for nuclear location of simian virus 40 large-T antigen.

Authors:  D Kalderon; W D Richardson; A F Markham; A E Smith
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

3.  Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.

Authors:  J Papkoff; I M Verma; T Hunter
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene.

Authors:  H Persson; P Leder
Journal:  Science       Date:  1984-08-17       Impact factor: 47.728

5.  The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein.

Authors:  J Papkoff; E A Nigg; T Hunter
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

6.  The nucleotide binding site detected by affinity labeling in the large T proteins of polyoma and SV40 viruses is distinct from their ATPase catalytic site.

Authors:  P Clertant; P Gaudray; E May; F Cuzin
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

7.  Expression of c-mos proto-oncogene transcripts in mouse tissues.

Authors:  F Propst; G F Vande Woude
Journal:  Nature       Date:  1985 Jun 6-12       Impact factor: 49.962

8.  P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity.

Authors:  W S Kloetzer; S A Maxwell; R B Arlinghaus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Expression and characterization of the human c-myc DNA-binding protein.

Authors:  R A Watt; A R Shatzman; M Rosenberg
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

10.  The transforming protein of the MC29-related virus CMII is a nuclear DNA-binding protein whereas MH2 codes for a cytoplasmic RNA-DNA binding polyprotein.

Authors:  T Bunte; I Greiser-Wilke; K Moelling
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  6 in total

1.  v-mos protein produced by in vitro translation has protein kinase activity.

Authors:  N K Herzog; M Nash; L S Ramagli; R B Arlinghaus
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

2.  Increased amount of a 25-kilodalton phosphoprotein after v-mos transfection of CHO cells.

Authors:  J K Mayo; K E Sampson; L D Adams; E R Crumm; S L Kelly; I Abraham
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

3.  Mouse Mos protooncogene product is present and functions during oogenesis.

Authors:  R S Paules; R Buccione; R C Moschel; G F Vande Woude; J J Eppig
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Mos in the oocyte: how to use MAPK independently of growth factors and transcription to control meiotic divisions.

Authors:  Aude Dupré; Olivier Haccard; Catherine Jessus
Journal:  J Signal Transduct       Date:  2010-12-19

5.  Replacement of lys 622 in the ATP binding domain of P100gag-mil abolishes the in vitro autophosphorylation of the protein and the biological properties of the v-mil oncogene of MH2 virus.

Authors:  F Denhez; B Heimann; L d'Auriol; T Graf; M Coquillaud; J Coll; F Galibert; K Moelling; D Stehelin; J Ghysdael
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

6.  Dose-dependent regulation of macrophage differentiation by mos mRNA in a human monocytic cell line.

Authors:  N Kurata; H Akiyama; T Taniyama; T Marunouchi
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.